Food and Wine Food and Wine

Is Viking Therapeutics, Inc. (VKTX) the Best Weight Loss Stock to Buy Now According to Hedge Funds?


Published on 2024-12-17 06:23:25 - MSN
  Print publication without navigation

  • We recently compiled a list of the 12 Best Weight Loss Stocks to Buy According to Hedge Funds. In this article, we are going to take a look at where Viking Therapeutics, Inc. (NASDAQ:VKTX) stands against the other weight loss stocks.

The article from MSN discusses the potential of Viking Therapeutics Inc. (VKTX) as a promising investment in the weight loss sector, particularly highlighted by its recent developments and hedge fund interest. Viking Therapeutics has gained attention due to its drug VK2735, which has shown significant weight loss results in early clinical trials, positioning the company as a potential competitor to established players like Eli Lilly and Novo Nordisk. The article notes that hedge funds have been increasing their stakes in VKTX, with notable investors like Citadel Investment Group and Renaissance Technologies showing interest. This surge in hedge fund investment is attributed to the promising data from Viking's trials, suggesting that the company could be a lucrative option for investors looking at the weight loss market. However, the article also cautions that while the stock has potential, it remains speculative due to the inherent risks associated with biotech investments, including the need for further successful trials and regulatory approval.

Read the Full MSN Article at:
[ https://www.msn.com/en-us/health/weightloss/is-viking-therapeutics-inc-vktx-the-best-weight-loss-stock-to-buy-now-according-to-hedge-funds/ar-AA1w0I1i ]